The application of NMR spectroscopy in the field of biology and medicine has grown consistently and steadily over the last 40 years or so, with the advancements in high field magnets, computational infrastructure and probe technology all aiding its progress to what is now a fundamental tool in the life sciences. Moreover, it has played an ever-increasing role in a plethora of applications within drug discovery and development including compound structure elucidation and chemical characterization, macromolecule secondary and tertiary structure determination, measurement of molecular dynamics and rates of turnover and magnetic resonance imaging (MRI). One area where NMR spectroscopy has really proved invaluable is that of metabolic profiling. The first reported application of NMR to metabolic profiling was in 1974, when Hoult et al. measured the complement of phosphorus-containing metabolites in isolated skeletal muscle by 31 P NMR spectroscopy. 1 This early work culminated in the emergence of a whole new field of metabolism science, which has in recent years been termed metabonomics or metabolomics, to describe the